4.6 Article

Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 294, 期 17, 页码 6986-7001

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.RA118.007204

关键词

Huntington disease; neurodegeneration; protein expression; protein purification; biophysics; small-angle X-ray scattering (SAXS); molecular dynamics

资金

  1. National Institutes of Health, NCI [HHSN26120080001E]
  2. Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research
  3. Huntington's Disease Society of America Berman/Topper Family Career Development Fellowship
  4. Natural Sciences and Engineering Research Council of Canada
  5. Huntington Society of Canada [RGPIN-2015-05939]
  6. CHDI Foundation
  7. SGC
  8. AbbVie [1097737]
  9. Bayer Pharma AG
  10. Boehringer Ingelheim
  11. Canada Foundation for Innovation
  12. Eshelman Institute for Innovation
  13. Genome Canada through Ontario Genomics Institute [OGI-055]
  14. Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant [115766]
  15. Janssen
  16. Merck KGaA, Darmstadt, Germany
  17. MSD
  18. Novartis Pharma AG
  19. Ontario Ministry of Research, Innovation and Science (MRIS)
  20. Pfizer
  21. Sao Paulo Research Foundation (FAPESP)
  22. Takeda
  23. Wellcome Trust

向作者/读者索取更多资源

The gene mutated in individuals with Huntington's disease (HD) encodes the 348-kDa huntingtin (HTT) protein. Pathogenic HD CAG-expansion mutations create a polyglutamine (polyQ) tract at the N terminus of HTT that expands above a critical threshold of approximate to 35 glutamine residues. The effect of these HD mutations on HTT is not well understood, in part because it is difficult to carry out biochemical, biophysical, and structural studies of this large protein. To facilitate such studies, here we have generated expression constructs for the scalable production of HTT in multiple eukaryotic expression systems. Our set of HTT expression clones comprised both N- and C-terminally FLAG-tagged HTT constructs with polyQ lengths representative of the general population, HD patients, and juvenile HD patients, as well as the more extreme polyQ expansions used in some HD tissue and animal models. Our expression system yielded milligram quantities of pure recombinant HTT protein, including many of the previously mapped post-translational modifications. We characterized both apo and HTT-HTT-associated protein 40 (HAP40) complex samples produced with this HD resource, demonstrating that this toolkit can be used to generate physiologically meaningful HTT complexes. We further demonstrate that these resources can produce sufficient material for protein-intensive experiments, such as small-angle X-ray scattering, providing biochemical insight into full-length HTT protein structure. The work outlined and the tools generated here lay a foundation for further biochemical and structural work on the HTT protein and for studying its functional interactions with other biomolecules.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据